Gil Aharon - 28 Apr 2026 Form 4 Insider Report for Neuraxis, INC (NRXS)

Reporting relationship: Director
Issuer ticker: NRXS
Reported as of: 28 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Apr 2026, 19:17:50 UTC
Prior SEC filing: 30 Jan 2026
Next SEC filing: 14 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Gilad Aharon

Key filing fact

Gil Aharon filed Form 4 for Neuraxis, INC (NRXS) on 30 Apr 2026.

Key facts

This page summarizes Gil Aharon's Form 4 filing for Neuraxis, INC (NRXS).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 30 Apr 2026, 19:17.

Change

Previous filing in this sequence was filed on 30 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001811824 Primary reporting owner

Aharon Gil

Relationship: Director
Address: 15 WELLESLEY STREET WEST, SUITE 326, TORONTO, ONTARIO, CANADA
Signature: /s/ Gilad Aharon
Signature date: 30 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NRXS transaction

Common Stock

Award

Transaction value
Shares: +12,304
Change %: +57%
Price
Shares after: 33,902
Date: 28 Apr 2026
Ownership: Direct
Footnotes: F1, F3

NRXS transaction

Common Stock

Award

Transaction value
Shares: +221,917
Change %: +78%
Price
Shares after: 508,055
Date: 28 Apr 2026
Ownership: By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.
Footnotes: F2, F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Includes (1) 21,598 shares of common stock issued to the Reporting Person as previously disclosed, and (2) 12,304 shares of common stock issued to the Reporting Person as a dividend on the Series B Preferred Stock owned by the Reporting Person.

Footnote F2

Includes (1) 286,138 shares of common stock purchased by Rosalind Master Fund L.P. in which the Reporting Person has indirect ownership as previously disclosed, and (2) 221,917 shares of common stock issued as a dividend on the Series B Preferred Stock owned by Rosalind Master Fund L.P.

Footnote F3

The number of shares of common stock issued as a dividend on the Series B Preferred Stock to Rosalind Master Fund L.P. and the Reporting Person were 221,917 and 12,304, respectively, and was determined by dividing the accrued and unpaid 8.5% cumulative dividends on the respective Series B Preferred Stock (from the investment date, through the applicable record or conversion date) by $2.38.

Footnote F4

Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.